Skip to content

XACT™ 83032-01Recalls & reported problems

Abbott Vascular Inc. · XACT™ Transcarotid Stent System 10.0 mm x 30 mm Tapered · Class 3 · Implant

All models of XACT (19)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 08717648356780), received between Nov 6, 2024 and Nov 6, 2024 — classified as 2 malfunctions.

The most frequently reported specific device problem is “Device Markings/Labelling Problem” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 2 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Device Markings/Labelling Problem2

Patient problems

  • No Clinical Signs, Symptoms or Conditions2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionNov 6, 2024Device Markings/Labelling Problem; Device Markings/Labelling Problem

    IT WAS REPORTED THAT THE CHIPBOARD BOX OF THE XACT SELF EXPANDING STENT SYSTEM (SESS) WAS NOTED TO HAVE THE CATHETER LENGTH LABELED AS "60 MM" RATHER THAN "60 CM". THE CATHETER LENGTH IS LABELED ON NUMEROUS AREAS OF DEVICE, INCLUDING THE CHIPBOARD BOX, POUCH LABEL AND IFU. ALL OTHER LOCATIONS WHERE THE CATHETER LENGTH IS LABELED WERE CORRECT IN INDICATING 60CM. THERE WAS NO DEVICE USE OR PATIENT INVOLVEMENT. THERE WAS NO REPORTED CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 20623072 ↗
  • MalfunctionNov 6, 2024Device Markings/Labelling Problem; Device Markings/Labelling Problem

    IT WAS REPORTED THAT THE CHIPBOARD BOX OF THE XACT SELF EXPANDING STENT SYSTEM (SESS) WAS NOTED TO HAVE THE CATHETER LENGTH LABELED AS "60 MM" RATHER THAN "60 CM". THE CATHETER LENGTH IS LABELED ON NUMEROUS AREAS OF DEVICE, INCLUDING THE CHIPBOARD BOX, POUCH LABEL AND IFU. ALL OTHER LOCATIONS WHERE THE CATHETER LENGTH IS LABELED WERE CORRECT IN INDICATING 60CM. THERE WAS NO DEVICE USE OR PATIENT INVOLVEMENT. THERE WAS NO REPORTED CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 20622417 ↗

Other STENT, CAROTID devices

All STENT, CAROTID devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page